SCHEMBL848854

SCHEMBL848854

CN1CCN(C(=O)NCc2ccc(Br)cc2)CC1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.76
▸ KMT2A Q03164 2/20 0.76
▸ KDM4E B2RXH2 2/20 0.54
▸ PDGFRB P09619 1/20 0.51
▸ PDGFRA P16234 1/20 0.51
▸ ALDH1A1 P00352 3/20 0.49
▸ DUSP3 P51452 2/20 0.49
▸ PTPN5 P54829 2/20 0.49
▸ PTPN11 Q06124 2/20 0.49
▸ TPSAB1 Q15661 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ MAPT P10636 1/20 0.49
▸ APOBEC3G Q9HC16 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ FPR3 P25089 1/20 0.48
▸ FPR2 P25090 1/20 0.48
▸ HRH3 Q9Y5N1 3/20 0.48
▸ TPSD1 Q9BZJ3 1/20 0.48
▸ TPSG1 Q9NRR2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28466660 0.86 MEN1 (0.78) MEN1KMT2AKDM4EALDH1A1TPSAB1
SCHEMBL5465071 0.86 MEN1 (1.00) MEN1KMT2AKDM4EPDGFRBPDGFRA
SCHEMBL3126965 0.86 NPC1 (0.57) MEN1KMT2AKDM4EPDGFRBPDGFRA
SCHEMBL5474021 0.85 MEN1 (0.76) MEN1KMT2AKDM4EALDH1A1TPSAB1
SCHEMBL5466273 0.85 KMT2A (0.76) MEN1KMT2AKDM4EPDGFRBPDGFRA
SCHEMBL5471150 0.84 MEN1 (0.75) MEN1KMT2AKDM4EALDH1A1TPSAB1
SCHEMBL5466489 0.82 MEN1 (0.72) MEN1KMT2APDGFRBPDGFRAMAPT
SCHEMBL5466245 0.82 MEN1 (0.72) MEN1KMT2AKDM4EALDH1A1TPSAB1
SCHEMBL29682382 0.82 MEN1 (0.51) MEN1KMT2AKDM4EPDGFRBPDGFRA
SCHEMBL13621149 0.82 MEN1 (0.71) MEN1KMT2AKDM4EALDH1A1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487517-B2 Spiroimidazolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2016-11-08 — — US disclosed
US-9487517-B2 Spiroimidazolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2016-11-08 — — US disclosed
US-9487517-B2 Spiroimidazolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2016-11-08 — — US disclosed
US-20160016956-A1 SPIROIMIDAZOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2016-01-21 — — US disclosed
US-20160016956-A1 SPIROIMIDAZOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2016-01-21 — — US disclosed
EP-2433940-B9 SPIROIMIDAZOLONE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2015-10-28 — — EP disclosed
US-9169254-B2 Spiroimidazolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2015-10-27 — — US disclosed
US-9169254-B2 Spiroimidazolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2015-10-27 — — US disclosed
US-9169254-B2 Spiroimidazolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2015-10-27 — — US disclosed
EP-2433940-B1 SPIROIMIDAZOLONE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2014-09-24 — — EP disclosed
US-20120270838-A1 SPIROIMIDAZOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2012-10-25 — — US disclosed
US-20120270838-A1 SPIROIMIDAZOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2012-10-25 — — US disclosed
US-20120270838-A1 SPIROIMIDAZOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2012-10-25 — — US disclosed
EP-2433940-A1 SPIROIMIDAZOLONE DERIVATIVE Chugai Seiyaku Kabushiki Kaisha (JP) 2012-03-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120270838-A1 SPIROIMIDAZOLONE DERIVATIVE WNK3, REN, SGK3 MEN1 276/4885KMT2A 3163/4885KDM4E 2949/4885
US-20160016956-A1 SPIROIMIDAZOLONE DERIVATIVE WNK3, REN, SGK3 MEN1 276/4885KMT2A 3163/4885KDM4E 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback